DE2353129A1 - Hydrazin-derivate - Google Patents

Hydrazin-derivate

Info

Publication number
DE2353129A1
DE2353129A1 DE19732353129 DE2353129A DE2353129A1 DE 2353129 A1 DE2353129 A1 DE 2353129A1 DE 19732353129 DE19732353129 DE 19732353129 DE 2353129 A DE2353129 A DE 2353129A DE 2353129 A1 DE2353129 A1 DE 2353129A1
Authority
DE
Germany
Prior art keywords
hydrazine
days
daily
cooh
derivs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19732353129
Other languages
German (de)
English (en)
Inventor
Dr Med Vet Emanuilo Alexandrov
Dipl-Chem Spassovska Christova
Dr Med Vet Angelov Ivan Ivanov
Dr Med Stojtschev Zan Stefanov
Dr Med Maneva Liljana Stoilova
Dipl-Chem Karamanov Geo Valkov
Prof Spassov Alexande Vassilev
Dipl-Ing Golovinski E Viktorov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INST BIOCHIMIA PRI BAN
Original Assignee
INST BIOCHIMIA PRI BAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST BIOCHIMIA PRI BAN filed Critical INST BIOCHIMIA PRI BAN
Publication of DE2353129A1 publication Critical patent/DE2353129A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19732353129 1972-10-25 1973-10-23 Hydrazin-derivate Pending DE2353129A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG21720A BG18271A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-10-25 1972-10-25

Publications (1)

Publication Number Publication Date
DE2353129A1 true DE2353129A1 (de) 1974-05-30

Family

ID=3898906

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19732353129 Pending DE2353129A1 (de) 1972-10-25 1973-10-23 Hydrazin-derivate

Country Status (4)

Country Link
JP (1) JPS504230A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG18271A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD107689A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2353129A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260057A3 (en) * 1986-09-02 1989-02-01 The University Of Melbourne 2-oxo-4-carboxy-pyrimidines

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6285015A (ja) * 1985-10-09 1987-04-18 Mitsui Toatsu Chem Inc 合成樹脂パルプの製造方法
JPS6285017A (ja) * 1985-10-09 1987-04-18 Mitsui Toatsu Chem Inc 合成樹脂パルプの製造方法
JPS6285018A (ja) * 1985-10-09 1987-04-18 Mitsui Toatsu Chem Inc 合成樹脂パルプの製造方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260057A3 (en) * 1986-09-02 1989-02-01 The University Of Melbourne 2-oxo-4-carboxy-pyrimidines

Also Published As

Publication number Publication date
DD107689A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-08-12
JPS504230A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-01-17
BG18271A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-10-25

Similar Documents

Publication Publication Date Title
DE69115526T2 (de) 2,4-Pyrimidindionderivate und diese enthaltende Arzneimittel
DE870556C (de) Verfahren zur Herstellung von Succinimiden
DE1670442A1 (de) Verfahren zur Herstellung von Laktaten von Benzimidazolderivaten
DE1958226C3 (de) Pyridoxin-alpha-ketoglutarat
DE2455353C3 (de) Substituierte a -Aminooxvcarbonsäurehydrazidderivate und ihre Säureadditionssalze sowie ihre Verwendung vnd Verfahren zur Herstellung derselben
DE3446371A1 (de) 5-pyrimidincarboxamide und 5-pyrimidinthiocarboxamide und ihre verwendung zur behandlung von leukaemie und tumoren
DE2353129A1 (de) Hydrazin-derivate
DE2818351C2 (de) N-[2-(α-Naphthoxy)-isobutyryl]-aminosäuren, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
DE2810095A1 (de) Pharmazeutische zubereitung mit immunsuppressiver wirkung
AT392469B (de) Verfahren zur herstellung von neuen chinolinderivaten
DE2830007A1 (de) Neue inosadiaminderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
DE69819192T2 (de) Neue cyanoaziridine zur behandlung von krebs
DE2714671A1 (de) Aromatische alpha-hydroxyamide
CH644596A5 (de) 2,6-dimethyl-1,4-dihydropyridin-3,5-dikarbonsaeureester und verfahren zu ihrer herstellung.
DE2328896A1 (de) Quaternaere phenylcycloalkylammoniumverbindungen und daraus hergestellte arzneipraeparate
DE3876341T2 (de) N-(halobenzoyl)-n'-2-halo-4(1,1,2-trifluor-2-(trifluor-methoxy)ethoxy)-phenylharnstoffe mit insektizider wirkung.
DE2029305A1 (de) 1,4 Dialkyl 3,6 diphenylepi(thia , dithia oder -tetrathia) 2,5 piperazindione
DE1302662B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE2536951B2 (de) Triazapentadiene, Verfahren zu ihrer Herstellung und diese enthaltende insektizide Mittel
DE3113087A1 (de) Verfahren zur herstellung von piperazin-derivaten und damit in zusammenhang stehende pharmazeutische ansaetze
DE1910283B2 (de) Gegen bestimmte Krebsformen wirksames Arzneimittel
DE2257360C2 (de) 1-(2-Chloräthyl)-1-nitroso-3-[(2-methyl-4-amino-pyrimidin-5-yl)methyl]harnstoff und Verfahren zu seiner Herstellung
DE2823266A1 (de) Prophylaktisches oder therapeutisches mittel zur behandlung von allergieerkrankungen und verfahren zu seiner herstellung
DE1470158A1 (de) 1,3-disubstituierte 1,2,3-Triazole und Verfahren zu ihrer Herstellung
AT286981B (de) Verfahren zur Herstellung von neuen substituierten Pyrazolderivaten und von deren Säureadditionssalzen